Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients
Clinical trial NCT00500422 · COMPLETED
Trial details
- NCT number
- NCT00500422
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2012-11-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.